Hartwig Büttner

1.4k total citations
53 papers, 1.0k citations indexed

About

Hartwig Büttner is a scholar working on Psychiatry and Mental health, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hartwig Büttner has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 13 papers in Pulmonary and Respiratory Medicine and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hartwig Büttner's work include Sexual function and dysfunction studies (21 papers), Hormonal and reproductive studies (11 papers) and Urinary Bladder and Prostate Research (11 papers). Hartwig Büttner is often cited by papers focused on Sexual function and dysfunction studies (21 papers), Hormonal and reproductive studies (11 papers) and Urinary Bladder and Prostate Research (11 papers). Hartwig Büttner collaborates with scholars based in Germany, United States and Italy. Hartwig Büttner's co-authors include Andreas Böhle, Carsten Henneges, Ignacio Moncada, Stefan Krüger, Alfred C. Feller, Friedhelm Sayk, Gerald Brock, John P. Mulhall, Francesco Montorsi and Hitendra Patel and has published in prestigious journals such as PLoS ONE, The Journal of Urology and International Journal of Cancer.

In The Last Decade

Hartwig Büttner

52 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hartwig Büttner Germany	18	435	428	310	234	231	53	1.0k
Ali̇ Ergen Türkiye	19	248 0.6×	269 0.6×	267 0.9×	165 0.7×	255 1.1×	61	985
Theodor Klotz Germany	16	274 0.6×	122 0.3×	247 0.8×	212 0.9×	164 0.7×	36	729
Luigi Rolle Italy	17	356 0.8×	445 1.0×	199 0.6×	117 0.5×	63 0.3×	51	833
Ioannis Sokolakis Germany	16	385 0.9×	204 0.5×	335 1.1×	215 0.9×	128 0.6×	74	820
Edward F. Ikeguchi United States	12	192 0.4×	185 0.4×	334 1.1×	115 0.5×	283 1.2×	19	873
W. Meinhardt Netherlands	20	166 0.4×	522 1.2×	290 0.9×	117 0.5×	278 1.2×	42	1.1k
Lianmin Luo China	19	213 0.5×	100 0.2×	115 0.4×	115 0.5×	145 0.6×	52	806
K Krajka Poland	11	182 0.4×	150 0.4×	126 0.4×	62 0.3×	119 0.5×	40	485
Erfan Amini Iran	15	81 0.2×	341 0.8×	140 0.5×	56 0.2×	213 0.9×	76	817

Countries citing papers authored by Hartwig Büttner

Since Specialization

Citations

This map shows the geographic impact of Hartwig Büttner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartwig Büttner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartwig Büttner more than expected).

Fields of papers citing papers by Hartwig Büttner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hartwig Büttner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartwig Büttner. The network helps show where Hartwig Büttner may publish in the future.

Co-authorship network of co-authors of Hartwig Büttner

This figure shows the co-authorship network connecting the top 25 collaborators of Hartwig Büttner. A scholar is included among the top collaborators of Hartwig Büttner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hartwig Büttner. Hartwig Büttner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Büttner, Hartwig, et al.. (2022). The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic. Molecular Biology Reports. 50(2). 1809–1816.

Montorsi, Francesco, Matthias Oelke, Carsten Henneges, et al.. (2016). Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy. European Urology. 70(3). 529–537. 17 indexed citations

Brock, Gerald, Francesco Montorsi, P. Costa, et al.. (2015). Effect of Tadalafil Once Daily on Penile Length Loss and Morning Erections in Patients After Bilateral Nerve-sparing Radical Prostatectomy: Results From a Randomized Controlled Trial. Urology. 85(5). 1090–1096. 22 indexed citations

Patel, Hitendra, Dapo Ilo, Nimish Shah, et al.. (2015). Effects of tadalafil treatment after bilateral nerve-sparing radical prostatectomy: quality of life, psychosocial outcomes, and treatment satisfaction results from a randomized, placebo-controlled phase IV study. BMC Urology. 15(1). 31–31. 18 indexed citations

Hatzichristou, Dimitrios, Gianluca d’Anzeo, Hartmut Porst, et al.. (2015). Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities. BMC Urology. 15(1). 111–111. 19 indexed citations

Fusco, Ferdinando, Gianluca d’Anzeo, Carsten Henneges, et al.. (2015). Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis. PLoS ONE. 10(8). e0135484–e0135484. 7 indexed citations

Hatzimouratidis, Konstantinos, Irène Buvat, Hartwig Büttner, et al.. (2014). Psychosocial outcomes after initial treatment of erectile dysfunction with tadalafil once daily, tadalafil on demand or sildenafil citrate on demand: results from a randomized, open-label study. International Journal of Impotence Research. 26(6). 223–229. 11 indexed citations

Buvat, Irène, Hartwig Büttner, Konstantinos Hatzimouratidis, et al.. (2013). Adherence to Initial PDE5 Inhibitor Treatment: Randomized OpenLabel Study Comparing Tadalafil Once a Day, Tadalafil on Demand, and Sildenafil on Demand in Patients with Erectile Dysfunction. The Journal of Sexual Medicine. 10(6). 1592–1602. 28 indexed citations

Montorsi, Francesco, Gerald Brock, Jens-Uwe Stolzenburg, et al.. (2013). Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT). European Urology. 65(3). 587–596. 179 indexed citations

10.

Porst, Hartmut, Mauro Gacci, Hartwig Büttner, Carsten Henneges, & Frank Boess. (2013). Tadalafil Once Daily in Men with Erectile Dysfunction: An Integrated Analysis of Data Obtained from 1913 Patients from Six Randomized, Double-blind, Placebo-controlled, Clinical Studies. European Urology. 65(2). 455–464. 38 indexed citations

11.

Schuette, Wolfgang, et al.. (2012). Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life. BMC Cancer. 12(1). 14–14. 13 indexed citations

12.

Porst, Hartmut, et al.. (2012). Chronic PDE-5 inhibition in patients with erectile dysfunction – a treatment approach using tadalafil once-daily. Expert Opinion on Pharmacotherapy. 13(10). 1481–1494. 17 indexed citations

13.

Porst, H., et al.. (2009). Chronische PDE-5-Hemmung bei erektiler Dysfunktion. Der Urologe. 48(11). 1318–1329. 6 indexed citations

14.

Böhle, Andreas, H. Leyh, Christian Frei, et al.. (2009). Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study. European Urology. 56(3). 495–503. 71 indexed citations

15.

Jocham, D., Heinz Pflüger, H Steiner, et al.. (2009). BCG versus Photodynamische Therapie (PDT) beim nicht muskelinvasiven Harnblasenkarzinom – eine multizentrische Phase-III-Studie. Aktuelle Urologie. 40(2). 91–99. 14 indexed citations

16.

Wirth, Alfred, Martina Manning, & Hartwig Büttner. (2006). Metabolisches Syndrom und erektile Dysfunktion. Der Urologe. 46(3). 287–292. 5 indexed citations

17.

Krüger, Stefan, et al.. (2002). Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome. International Journal of Oncology. 21(5). 981–7. 67 indexed citations

18.

Krüger, Stefan, et al.. (2002). HER2 overexpression in muscle‐invasive urothelial carcinoma of the bladder: Prognostic implications. International Journal of Cancer. 102(5). 514–518. 147 indexed citations

19.

Doehn, Christian, Paolo Fornara, Hartwig Büttner, & D. Jocham. (1999). The transplant recipient with elevated creatinine, and normal ultrasonography—detection of ureteral stenosis by magnetic resonance tomography. Nephrology Dialysis Transplantation. 14(10). 2492–2494. 1 indexed citations

20.

Büttner, Hartwig. (1967). [Is hematocrit determination using centrifugation or conductometry preferable?].. PubMed. 92(51). 2365–2365. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact